Skip to main content
PolicySpeak
← All files
ISP

International Society for Pharmaceutical Engineering(ISPE)

Other · United States · EU Transparency Register 316626227774-56

2
positions filed
in the 583 files tracked
1
legislative file
of 583 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1365 trade and business associations on this site, they rank #998 by legislative files engaged — a count of participation, not a measure of influence.

3.5
declared lobbying FTE
self-declared
€600K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2017
in the register since

Declares membership of

  • ISPE participates in a group of associations coordinated by the European Federation of Pharmaceutical Industries and…

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).

Register category
Trade and business associations
Registered as
International Society for Pharmaceutical Engineering (ISPE)
Head office
Rockville, United states

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track International in PolicySpeak: request access →

Work at International Society for Pharmaceutical Engineering(ISPE)? so we know who speaks for it.

Follow the file International Society for Pharmaceutical Engineering(ISPE) engages with

One email on Tuesdays when a new position is filed on this file, from International Society for Pharmaceutical Engineering(ISPE) or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

International Society for Pharmaceutical Engineering(ISPE) filed 2 positions between 2 Nov 2023 and 3 Nov 2023, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Medicinal products for human usefiled 3 Nov 2023source

2 November 2023 European Commission, Directorate-General for Health and Food Safety Reference: CELEX number: 52023PC0193 Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU)…

Medicinal products for human usefiled 2 Nov 2023PDFsource

2 November 2023 European Commission, Directorate-General for Health and Food Safety Reference: CELEX number: 52023PC0192 Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC COM/2023/192 final Dear Sir or Madam, The International Society for Pharmaceutical Engineering (ISPE)…

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put International Society for Pharmaceutical Engineering(ISPE) next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from International Society for Pharmaceutical Engineering(ISPE)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.